share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

SEC announcement ·  Jun 14 05:40
Summary by Futu AI
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.